To date, this International Convention is still on track.
The health and safety of our attendees, exhibitors and speakers from various nations are of an ultimate importance and therefore, BIO KOREA is closely monitoring the measures and directives around the COVID-19 outbreak. As an international bio convention, we will thoroughly observe the current Coronavirus situation in a global aspect in order to determine the best comprehensive countermeasures.
BIO KOREA will take all actions necessary to abide by the policies and guidelines provided by related authorities in accordance with the present status, and will ensure the provision of regular updates on any changes and announcements to enable fluent preparation and operation of the event.
Save the date!
AWEX, in collaboration with the cluster and KPBMA, is organizing a stand at the BIO KOREA exhibition in Seoul from May 20 to 22, 2020 at the COEX Convention Center.
The health sector in South Korea
The Republic of Korea has become a major player in the life sciences sector. Korean companies such as SK Biopharmaceuticals, Samsung Biologics, Daewoong Pharmaceutical and Celltrion are successfully positioning themselves on the global markets. They are encouraged by the Korean government, which is banking on this economic sector as a new vector for exports.
The Korean pharmaceutical industry is among the top 13 in the world thanks to the country's dedication to developing dynamic solutions. South Korea has also become a major player in the area of medical imaging.
Any practical information ?
Contact Catherine Collet - (+32) 02/421.85.08 - [email protected]
Do you want a specific support?
Contact Marc Dechamps, Director International Affairs chez BioWin - [email protected]
COEX, 159 Samseong dong, Gangnam-gu, Seoul 135-731, South Korea